CHAPTER 1: INTRODUCTION
1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS FOR STAKEHOLDERS
1.3. KEY MARKET SEGMENTS
1.4. KEY MARKET PLAYERS
1.5. RESEARCH METHODOLOGY
1.5.1. Secondary research
1.5.2. Primary research
1.5.3. Analyst tools & models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. KEY FINDINGS
2.1.1. Top impacting factors
2.1.2. Top investment pockets
2.2. CXO PERSPECTIVE
CHAPTER 3: MARKET OVERVIEW
3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FORCES SHAPING THE GLOBAL E-PRESCRIBING MARKET
3.3. VALUE CHAIN ANALYSIS
3.4. MARKET DYNAMICS
3.4.1. Drivers
3.4.1.1. Government initiatives and incentive programs
3.4.1.2. Rise in focus on the reduction of fraud and abuse of controlled substances
3.4.1.3. Need to curtail escalating healthcare costs
3.4.2. Restraints
3.4.2.1. High cost of systems
3.4.2.2. Security & workflow issues
3.4.3. Opportunities
3.4.3.1. Growth in the developing countries across Asia-Pacific
3.5. INDUSTRY ROADMAP OF E-PRESCRIBING
3.6. IMPACT OF GOVERNMENT REGULATIONS ON THE GLOBAL E-PRESCRIBING MARKET
CHAPTER 4: E-PRESCRIBING MARKET, BY COMPONENT
4.1. OVERVIEW
4.2. SOLUTIONS
4.2.1. Key market trends, growth factors, and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market analysis, by country
4.3. SERVICES
4.3.1. Key market trends, growth factors, and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market analysis, by country
CHAPTER 5: E-PRESCRIBING MARKET, BY DEPLOYMENT
5.1. OVERVIEW
5.2. WEB & CLOUD-BASED
5.2.1. Key market trends, growth factors, and opportunities
5.2.2. Market size and forecast, by region
5.2.3. Market analysis, by country
5.3. ON-PREMISE
5.3.1. Key market trends, growth factors, and opportunities
5.3.2. Market size and forecast, by region
5.3.3. Market analysis, by country
CHAPTER 6: E-PRESCRIBING MARKET, BY END USER
6.1. OVERVIEW
6.2. HOSPITALS
6.2.1. Key market trends, growth factors, and opportunities
6.2.2. Market size and forecast, by region
6.2.3. Market analysis, by country
6.3. OFFICE-BASED PHYSICIANS
6.3.1. Key market trends, growth factors, and opportunities
6.3.2. Market size and forecast, by region
6.3.3. Market analysis, by country
6.4. PHARMACEUTICALS
6.4.1. Key market trends, growth factors, and opportunities
6.4.2. Market size and forecast, by region
6.4.3. Market analysis, by country
CHAPTER 7: E-PRESCRIBING MARKET, BY REGION
7.1. OVERVIEW
7.1.1. Market size and forecast, by region
7.2. NORTH AMERICA
7.2.1. Key market trends, growth factors, and opportunities
7.2.2. Market size and forecast, by component
7.2.3. Market size and forecast, by deployment
7.2.4. Market size and forecast, by end user
7.2.5. Market analysis, by country
7.2.5.1. U.S.
7.2.5.1.1. Market size and forecast, by component
7.2.5.1.2. Market size and forecast, by deployment
7.2.5.1.3. Market size and forecast, by end user
7.2.5.2. Canada
7.2.5.2.1. Market size and forecast, by component
7.2.5.2.2. Market size and forecast, by deployment
7.2.5.2.3. Market size and forecast, by end user
7.3. EUROPE
7.3.1. Key market trends, growth factors, and opportunities
7.3.2. Market size and forecast, by component
7.3.3. Market size and forecast, by deployment
7.3.4. Market size and forecast, by end user
7.3.5. Market analysis, by country
7.3.5.1. Germany
7.3.5.1.1. Market size and forecast, by component
7.3.5.1.2. Market size and forecast, by deployment
7.3.5.1.3. Market size and forecast, by end user
7.3.5.2. UK
7.3.5.2.1. Market size and forecast, by component
7.3.5.2.2. Market size and forecast, by deployment
7.3.5.2.3. Market size and forecast, by end user
7.3.5.3. France
7.3.5.3.1. Market size and forecast, by component
7.3.5.3.2. Market size and forecast, by deployment
7.3.5.3.3. Market size and forecast, by end user
7.3.5.4. Rest of Europe
7.3.5.4.1. Market size and forecast, by component
7.3.5.4.2. Market size and forecast, by deployment
7.3.5.4.3. Market size and forecast, by end user
7.4. ASIA-PACIFIC
7.4.1. Key market trends, growth factors, and opportunities
7.4.2. Market size and forecast, by component
7.4.3. Market size and forecast, by deployment
7.4.4. Market size and forecast, by end user
7.4.5. Market analysis, by country
7.4.5.1. Japan
7.4.5.1.1. Market size and forecast, by component
7.4.5.1.2. Market size and forecast, by deployment
7.4.5.1.3. Market size and forecast, by end user
7.4.5.2. China
7.4.5.2.1. Market size and forecast, by component
7.4.5.2.2. Market size and forecast, by deployment
7.4.5.2.3. Market size and forecast, by end user
7.4.5.3. India
7.4.5.3.1. Market size and forecast, by component
7.4.5.3.2. Market size and forecast, by deployment
7.4.5.3.3. Market size and forecast, by end user
7.4.5.4. Rest of Asia-Pacific
7.4.5.4.1. Market size and forecast, by component
7.4.5.4.2. Market size and forecast, by deployment
7.4.5.4.3. Market size and forecast, by end user
7.5. LAMEA
7.5.1. Key market trends, growth factors, and opportunities
7.5.2. Market size and forecast, by component
7.5.3. Market size and forecast, by deployment
7.5.4. Market size and forecast, by end user
7.5.5. Market analysis, by country
7.5.5.1. Latin America
7.5.5.1.1. Market size and forecast, by component
7.5.5.1.2. Market size and forecast, by deployment
7.5.5.1.3. Market size and forecast, by end user
7.5.5.2. Middle East
7.5.5.2.1. Market size and forecast, by component
7.5.5.2.2. Market size and forecast, by deployment
7.5.5.2.3. Market size and forecast, by end user
7.5.5.3. Africa
7.5.5.3.1. Market size and forecast, by component
7.5.5.3.2. Market size and forecast, by deployment
7.5.5.3.3. Market size and forecast, by end user
CHAPTER 8: COMPETITIVE LANDSCAPE
8.1. KEY PLAYERS POSITIONING ANALYSIS, 2018
8.2. TOP WINNING STRATEGIES
8.3. KEY DEVELOPMENTS
8.3.1. Product launches
8.3.2. Partnership
8.3.3. Business expansion
8.3.4. Acquisition
8.3.5. Collaboration
8.4. PATENT ANALYSIS
8.4.1. By region (2016-2019)
8.4.2. By applicant
CHAPTER 9: COMPANY PROFILE
9.1. ALLSCRIPTS HEALTHCARE SOLUTIONS, INC.
9.1.1. Company overview
9.1.2. Key Executives
9.1.3. Company snapshot
9.1.4. Operating business segments
9.1.5. Product portfolio
9.1.6. R&D Expenditure
9.1.7. Business performance
9.1.8. Key strategic moves and developments
9.2. ATHENAHEALTH, INC.
9.2.1. Company overview
9.2.2. Key Executives
9.2.3. Company snapshot
9.2.4. Product portfolio
9.2.5. Key strategic moves and developments
9.3. CERNER CORPORATION
9.3.1. Company overview
9.3.2. Key Executives
9.3.3. Company snapshot
9.3.4. Product portfolio
9.3.5. Business performance
9.3.6. Key strategic moves and developments
9.4. CHANGE HEALTHCARE
9.4.1. Company overview
9.4.2. Key Executives
9.4.3. Company snapshot
9.4.4. Product portfolio
9.4.5. Key strategic moves and developments
9.5. DRFIRST
9.5.1. Company overview
9.5.2. Key Executives
9.5.3. Company snapshot
9.5.4. Product portfolio
9.5.5. Key strategic moves and developments
9.6. ECLINICALWORKS
9.6.1. Company overview
9.6.2. Key Executives
9.6.3. Company snapshot
9.6.4. Product portfolio
9.6.5. Key strategic moves and developments
9.7. EPIC SYSTEMS CORPORATION
9.7.1. Company overview
9.7.2. Key Executives
9.7.3. Company snapshot
9.7.4. Product portfolio
9.7.5. Key strategic moves and developments
9.8. MEDICAL INFORMATION TECHNOLOGY, INC.
9.8.1. Company overview
9.8.2. Key Executives
9.8.3. Company snapshot
9.8.4. Product portfolio
9.8.5. Key strategic moves and developments
9.9. PRACTICE FUSION, INC.
9.9.1. Company overview
9.9.2. Key Executives
9.9.3. Company snapshot
9.9.4. Product portfolio
9.9.5. Key strategic moves and developments
9.10. SURESCRIPTS
9.10.1. Company overview
9.10.2. Key Executives
9.10.3. Company snapshot
9.10.4. Product portfolio
9.10.5. Key strategic moves and developments